ScreenerHero

BYSIBeyondSpring Inc.

NAS · US · Healthcare · Biotechnology · beyondspringpharma.com
0.7201USD-0.26%Mkt Cap: 29.61M $P/E: —

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: t…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap29.61M $
Enterprise Value22.79M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.01M $
Revenue/Share—
Last Price0.7201 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.53
PEG—
EV/EBITDA-2.72
EV/Revenue—
P/S—
P/B-0.83
EPS (TTM)-0.18
EPS (Forward)-0.47
52W Range
0.70001% of range2.440
52W High2.440 USD
52W Low0.7000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE3.13%
ROA-3.88%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.77M $
CapEx (TTM)50.00K $
FCF Margin—
FCF Yield36.68%
Net Debt-6.36M $
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity-0.01
Current Ratio0.70
Quick Ratio0.46
Book Value/Sh-0.8650 USD
Cash/Share0.1590 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.12M
Float31.95M
Insiders14.27%
Institutions14.80%
Short Interest
Short Ratio81.4d
Short % Float6.58%
Short % Out.5.46%
Shares Short2.24M
Short (prev mo.)2.22M
Technical
SMA 501.296 (-44.4%)
SMA 2001.583 (-54.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)1.35M
Avg Vol (10d)4.07M
Technical Indicators
RSI (14)32.0
MACD-0.1653
MACD Signal-0.1586
MACD Hist.-0.0067
BB Upper1.313 USD
BB Middle0.9584 USD
BB Lower0.6042 USD
BB Width73.92%
ATR (14)0.1254 USD
Vol Ratio (20d)0.03x